Raptr.ai

Curated by Signal

A platform utilizing artificial intelligence to optimize bioprocess data, enabling the design of optimal experiment plans and accelerating the development of products

Life Sciences Technologyraptr.ai

Overview

A platform utilizing artificial intelligence to optimize bioprocess data, enabling the design of optimal experiment plans and accelerating the development of products. It is an artificial intelligence (AI) platform that enables bioprocess data optimization, allowing companies to design optimal experiment plans. Utilizing AI, the platform streamlines the bioprocess development process.

Key facts

Founded: 2024
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Ambulatory Monitoring
Ambulatory Monitoring provides long term Physiological and Environmental monitoring solutions.
Life Sciences TechnologyArdsley, United States
Clover Therapeutics
Developer of therapeutic solutions for treating age related diseases
Life Sciences TechnologyBelleville, United States
NuEar
Develops wireless and digital hearing aids
Life Sciences TechnologyEden Prairie, United States

About Raptr.ai

What does Raptr.ai do?

A platform utilizing artificial intelligence to optimize bioprocess data, enabling the design of optimal experiment plans and accelerating the development of products.

Where is Raptr.ai headquartered?

Raptr.ai is headquartered in Cambridge, United States.

When was Raptr.ai founded?

Raptr.ai was founded in 2024.

Which sector is Raptr.ai in?

Raptr.ai operates in Life Sciences Technology.

Who are Raptr.ai's competitors?

Companies similar to Raptr.ai include Ambulatory Monitoring, Clover Therapeutics, and NuEar.